Taro Pharmaceuticals Canada is a global healthcare company, proudly manufacturing in Canada since 1984. Established in 1950, Taro is a research-driven specialty pharmaceutical company that develops, manufactures, and markets affordable prescription and over-the-counter medications.
Supported by its parent company, Sun Pharma, the world's 5th largest specialty generic pharmaceutical company, Taro is a powerful global presence. With world-class production facilities in Brampton, Ontario and nearly 600 Canadian employees, Taro Canada offers a uniquely Canadian perspective.
Taro's Canadian focus on dermatology makes it a leading manufacturer and supplier of topical products such as creams, ointments, and gels. This investment in niche markets continues to differentiate Taro from its competitors.
Specializing in generic prescription products and also producing over-the-counter and brand-name drugs, Taro's strong research program and niche strategy have positioned it as a central player in the specialty pharmaceutical sector.
There is no investment information
No recent news or press coverage available for TARO PHARMACEUTICALS CANADA .